NCT03107013View on ClinicalTrials.gov

A Study to Investigate the Mass Balance of BTD-001

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

May 1, 2017

Study Completion Date

May 1, 2017

Conditions
Molecular Mechanisms of Pharmacological Action
Interventions
DRUG

[14C]-BTD-001

Carbon-14 labeled BTD-001

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington

Sponsors
All Listed Sponsors
lead

Balance Therapeutics

INDUSTRY